PCG:NYSEPacific Gas & Electric Co. Analysis
Data as of 2026-06-07 - not real-time
$17.11
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
PCG is trading just above its 20‑day SMA and slightly below the 50‑day SMA, while the 200‑day SMA remains supportive, indicating a neutral technical stance. The MACD histogram has turned positive and the RSI sits in the upper‑mid range, suggesting modest upside momentum without imminent overbought pressure. A quarterly cash dividend of $0.05 has been announced, yielding just over 1 % and supported by a low payout ratio, which adds income appeal. Valuation metrics show a P/E well below the industry average and a DCF‑derived fair value that is more than double the current price, pointing to a substantial undervaluation. The implied upside of over 30 % reinforces the case for price appreciation.
However, the balance sheet is heavily weighted toward debt, with a debt‑to‑equity ratio that dwarfs peers and free cash flow running negative, raising concerns about long‑term financial flexibility. The utility’s exposure is concentrated in California, exposing it to heightened regulatory and wildfire‑related risks that can affect earnings. Despite these headwinds, regulated revenue growth of roughly 15 % and improving EPS trends provide a solid earnings foundation. Combined with a low beta and defensive sector profile, the stock offers a blend of value and modest growth characteristics. Investors should weigh the attractive valuation against the structural debt and regulatory environment when deciding on exposure.
However, the balance sheet is heavily weighted toward debt, with a debt‑to‑equity ratio that dwarfs peers and free cash flow running negative, raising concerns about long‑term financial flexibility. The utility’s exposure is concentrated in California, exposing it to heightened regulatory and wildfire‑related risks that can affect earnings. Despite these headwinds, regulated revenue growth of roughly 15 % and improving EPS trends provide a solid earnings foundation. Combined with a low beta and defensive sector profile, the stock offers a blend of value and modest growth characteristics. Investors should weigh the attractive valuation against the structural debt and regulatory environment when deciding on exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical indicators are neutral with price near support
- Upcoming dividend provides modest income
- Volume trend is decreasing, limiting short‑term upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued price versus DCF and industry peers
- Revenue and EPS growth supporting earnings outlook
- Attractive dividend yield with low payout
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt load and negative free cash flow constrain financial flexibility
- Regulatory and geographic concentration risk in California
- Stable regulated cash flows and low beta provide defensive profile
Key Metrics & Analysis
Financial Health
Revenue Growth15.00%
Profit Margin11.01%
P/E Ratio13.3
ROE8.83%
ROA2.53%
Debt/Equity187.87
P/B Ratio1.2
Op. Cash Flow$8.3B
Free Cash Flow$-5572125184
Industry P/E22.6
Technical Analysis
TrendNeutral
RSI59.1
Support$15.28
Resistance$17.25
MA 20$16.46
MA 50$16.88
MA 200$16.36
MACDBullish
VolumeDecreasing
Fear & Greed Index83.02
Valuation
Fair Value$36.89
Target Price$22.59
Upside/Downside32.05%
GradeUndervalued
TypeBlend
Dividend Yield1.17%
Risk Assessment
Beta0.39
Volatility26.16%
Sector RiskLow
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.